or FR940810-0-00065 3 173 416 903
partially FR940810-0-00065 2 174 762
explain FR940810-0-00065 1 175
the FR940810-0-00065 36 176 210 226 258 264 279 293 316 372 394 405 462 465 503 541 583 628 642 648 664 694 765 771 795 832 842 867 871 879 907 917 922 938 941 972 979
observations FR940810-0-00065 1 177
[ FR940810-0-00065 2 178 216
that FR940810-0-00065 27 179 281 310 318 375 404 428 467 474 492 506 527 585 599 607 618 627 663 703 721 825 834 863 882 921 958 971
exposure FR940810-0-00065 8 180 321 329 406 429 611 678 789
to FR940810-0-00065 16 181 209 231 326 343 413 430 559 610 712 737 758 794 878 996 1003
amphiboles FR940810-0-00065 2 182 768
are FR940810-0-00065 5 183 459 655 707 743
associated FR940810-0-00065 1 184
with FR940810-0-00065 2 185 991
a FR940810-0-00065 8 186 261 441 468 477 545 557 747
higher FR940810-0-00065 1 187
prevalence FR940810-0-00065 1 188
of FR940810-0-00065 32 189 199 217 228 263 269 272 295 298 309 315 371 543 571 647 651 657 667 689 729 749 781 808 847 870 931 935 940 944 974 978 983
mesothelioma FR940810-0-00065 6 190 337 668 948 963 975
] FR940810-0-00065 2 191 225
in FR940810-0-00065 25 192 203 257 313 324 339 369 447 530 556 573 645 693 764 770 820 841 886 889 896 906 926 946 976 1001
human FR940810-0-00065 2 193 600
*** FR940810-0-00065 6 194 196 215 778 968 993
population FR940810-0-00065 1 195
. FR940810-0-00065 35 197 237 241 250 288 312 349 365 368 388 439 446 456 483 488 517 522 547 564 577 592 624 640 682 709 740 754 779 810 814 855 913 916 1008 1013
nonn FR940810-0-00065 1 198
fiber FR940810-0-00065 7 200 273 300 614 732 783 874
type FR940810-0-00065 1 201
differences FR940810-0-00065 1 202
animal FR940810-0-00065 2 204 619
experiments FR940810-0-00065 1 205
may FR940810-0-00065 2 206 790
be FR940810-0-00065 7 207 232 284 411 435 738 997
related FR940810-0-00065 1 208
much FR940810-0-00065 1 211
shorter FR940810-0-00065 1 212
life FR940810-0-00065 1 213
span FR940810-0-00065 1 214
experimental FR940810-0-00065 1 218
animals FR940810-0-00065 1 219
, FR940810-0-00065 40 220 239 243 275 330 352 354 356 358 362 381 391 423 442 449 454 458 485 502 524 533 539 555 561 567 580 596 616 654 659 673 686 698 824 830 858 881 894 925 949
which FR940810-0-00065 4 221 334 402 798
would FR940810-0-00065 1 222
not FR940810-0-00065 7 223 632 744 837 850 901 965
allow FR940810-0-00065 1 224
effects FR940810-0-00065 1 227
varying FR940810-0-00065 1 229
tissuepersistence FR940810-0-00065 1 230
expressed FR940810-0-00065 1 233
'' FR940810-0-00065 7 234 472 514 636 811 910 1005
( FR940810-0-00065 13 235 346 418 437 481 515 562 723 812 853 911 953 1006
doc FR940810-0-00065 1 236
33c FR940810-0-00065 1 238
ex FR940810-0-00065 8 240 348 438 482 516 563 813 1007
99 FR940810-0-00065 1 242
p.18 FR940810-0-00065 1 244
; FR940810-0-00065 1 245
51 FR940810-0-00065 1 246
fr FR940810-0-00065 1 247
22628 FR940810-0-00065 1 248
) FR940810-0-00065 13 249 367 422 445 487 521 566 725 816 857 915 955 1012
therefore FR940810-0-00065 1 251
osha FR940810-0-00065 5 252 495 525 625 700
had FR940810-0-00065 3 253 277 701
reviewed FR940810-0-00065 1 254
and FR940810-0-00065 14 255 276 307 383 432 536 550 581 617 660 699 761 892 969
evaluated FR940810-0-00065 1 256
earlier FR940810-0-00065 2 259 695
rulemaking FR940810-0-00065 3 260 532 697
portion FR940810-0-00065 1 262
evidence FR940810-0-00065 5 265 291 387 862 957
submitted FR940810-0-00065 6 266 303 332 385 393 644
by FR940810-0-00065 4 267 304 452 717
proponents FR940810-0-00065 1 268
differential FR940810-0-00065 2 270 296
regulation FR940810-0-00065 1 271
types FR940810-0-00065 4 274 301 615 875
rejected FR940810-0-00065 1 278
claim FR940810-0-00065 3 280 374 466
chrysotile FR940810-0-00065 16 282 319 344 376 409 475 507 586 652 677 755 835 864 945 959 992
should FR940810-0-00065 2 283 410
regulated FR940810-0-00065 1 285
less FR940810-0-00065 1 286
stringently FR940810-0-00065 1 287
some FR940810-0-00065 1 289
new FR940810-0-00065 2 290 851
on FR940810-0-00065 2 292 637
issue FR940810-0-00065 2 294 939
risks FR940810-0-00065 2 297 511
asbestos FR940810-0-00065 12 299 320 328 345 434 499 508 587 653 696 848 986
was FR940810-0-00065 3 302 426 691
both FR940810-0-00065 1 305
supporters FR940810-0-00065 1 306
detractors FR940810-0-00065 1 308
theory FR940810-0-00065 1 311
support FR940810-0-00065 3 314 370 646
position FR940810-0-00065 1 317
is FR940810-0-00065 11 322 608 670 715 756 849 860 865 884 900 964
equivalent FR940810-0-00065 1 323
risk FR940810-0-00065 6 325 480 500 591 606 650
amphibole FR940810-0-00065 2 327 672
bctd FR940810-0-00065 2 331 817
studies FR940810-0-00065 5 333 601 643 706 936
indicated FR940810-0-00065 1 335
excess FR940810-0-00065 2 336 603
cases FR940810-0-00065 1 338
workers FR940810-0-00065 2 340 987
exposed FR940810-0-00065 2 341 985
solely FR940810-0-00065 1 342
see FR940810-0-00065 1 347
119 FR940810-0-00065 1 350
c FR940810-0-00065 2 351 361
1136 FR940810-0-00065 1 353
125 FR940810-0-00065 1 355
att.6 FR940810-0-00065 1 357
143 FR940810-0-00065 2 359 363
att FR940810-0-00065 2 360 364
d FR940810-0-00065 1 366
opposing FR940810-0-00065 1 373
has FR940810-0-00065 4 377 512 631 735
reduced FR940810-0-00065 3 378 412 478
carcinogenic FR940810-0-00065 3 379 479 796
potential FR940810-0-00065 1 380
aiana FR940810-0-00065 3 382 392 490
sba FR940810-0-00065 1 384
additional FR940810-0-00065 2 386 710
for FR940810-0-00065 5 389 408 464 751 773
example FR940810-0-00065 1 390
world FR940810-0-00065 1 395
health FR940810-0-00065 1 396
organization FR940810-0-00065 1 397
's FR940810-0-00065 2 398 578
1989 FR940810-0-00065 1 399
working FR940810-0-00065 1 400
report FR940810-0-00065 2 401 924
recommended FR940810-0-00065 2 403 427
limit FR940810-0-00065 1 407
1 FR940810-0-00065 1 414
f/cc FR940810-0-00065 1 415
below FR940810-0-00065 1 417
8 FR940810-0-00065 1 419
hour FR940810-0-00065 1 420
twa FR940810-0-00065 1 421
where FR940810-0-00065 2 424 898
it FR940810-0-00065 3 425 883 899
crocidolite FR940810-0-00065 1 431
amosite FR940810-0-00065 1 433
prohibited FR940810-0-00065 1 436
21 FR940810-0-00065 1 440
p. FR940810-0-00065 2 443 1010
9 FR940810-0-00065 1 444
particular FR940810-0-00065 1 448
two FR940810-0-00065 2 450 981
papers FR940810-0-00065 1 451
mossman FR940810-0-00065 2 453 574
et FR940810-0-00065 3 455 575 594
al FR940810-0-00065 3 457 576 595
cited FR940810-0-00065 1 460
as FR940810-0-00065 5 461 683 746 839 844
basis FR940810-0-00065 1 463
scientific FR940810-0-00065 3 469 504 629
`` FR940810-0-00065 9 470 493 634 722 826 866 952 967 980
consensus FR940810-0-00065 4 471 505 546 635
believes FR940810-0-00065 2 473 626
carries FR940810-0-00065 2 476 588
1153 FR940810-0-00065 1 484
151 FR940810-0-00065 1 486
thus FR940810-0-00065 1 489
states FR940810-0-00065 1 491
since FR940810-0-00065 1 494
issued FR940810-0-00065 1 496
its FR940810-0-00065 4 497 821 929 932
1984 FR940810-0-00065 1 498
assessment FR940810-0-00065 1 501
poses FR940810-0-00065 1 509
lesser FR940810-0-00065 1 510
solidified FR940810-0-00065 1 513
142 FR940810-0-00065 1 518
at FR940810-0-00065 3 519 876 999
3 FR940810-0-00065 1 520
however FR940810-0-00065 1 523
notes FR940810-0-00065 3 526 720 920
various FR940810-0-00065 2 528 569
participants FR940810-0-00065 1 529
this FR940810-0-00065 3 531 687 713
including FR940810-0-00065 2 534 552
niosh FR940810-0-00065 1 535
dr. FR940810-0-00065 4 537 548 553 827
nicholson FR940810-0-00065 3 538 549 593
disputed FR940810-0-00065 1 540
existence FR940810-0-00065 1 542
such FR940810-0-00065 1 544
others FR940810-0-00065 2 551 661
landrigan FR940810-0-00065 2 554 828
letter FR940810-0-00065 1 558
science FR940810-0-00065 1 560
1155 FR940810-0-00065 1 565
dispute FR940810-0-00065 1 568
interpretations FR940810-0-00065 1 570
data FR940810-0-00065 3 572 734 742
paper FR940810-0-00065 1 579
challenge FR940810-0-00065 1 582
conclusion FR940810-0-00065 1 584
little FR940810-0-00065 1 589
cancer FR940810-0-00065 3 590 605 809
point FR940810-0-00065 1 597
out FR940810-0-00065 2 598 819
show FR940810-0-00065 1 602
lung FR940810-0-00065 5 604 665 704 731 766
proportionate FR940810-0-00065 1 609
across FR940810-0-00065 1 612
all FR940810-0-00065 1 613
tests FR940810-0-00065 1 620
confirm FR940810-0-00065 1 621
these FR940810-0-00065 3 622 638 741
relationships FR940810-0-00065 1 623
community FR940810-0-00065 1 630
achieved FR940810-0-00065 1 633
issues FR940810-0-00065 1 639
among FR940810-0-00065 1 641
lowered FR940810-0-00065 1 649
those FR940810-0-00065 1 656
churg FR940810-0-00065 1 658
showing FR940810-0-00065 1 662
burden FR940810-0-00065 3 666 705 733
victims FR940810-0-00065 1 669
predominantly FR940810-0-00065 1 671
even FR940810-0-00065 2 674 895
though FR940810-0-00065 1 675
high FR940810-0-00065 1 676
levels FR940810-0-00065 1 679
were FR940810-0-00065 1 680
reported FR940810-0-00065 1 681
noted FR940810-0-00065 1 684
above FR940810-0-00065 1 685
line FR940810-0-00065 1 688
argument FR940810-0-00065 2 690 714
presented FR940810-0-00065 1 692
concluded FR940810-0-00065 2 702 970
inconclusive FR940810-0-00065 1 708
response FR940810-0-00065 1 711
provided FR940810-0-00065 1 716
dement FR940810-0-00065 1 718
who FR940810-0-00065 2 719 988
t FR940810-0-00065 2 724 954
he FR940810-0-00065 2 726 956
biological FR940810-0-00065 1 727
significance FR940810-0-00065 1 728
postm FR940810-0-00065 1 730
yet FR940810-0-00065 1 736
established FR940810-0-00065 1 739
useful FR940810-0-00065 1 745
predictor FR940810-0-00065 1 748
disease FR940810-0-00065 1 750
several FR940810-0-00065 1 752
reasons FR940810-0-00065 1 753
known FR940810-0-00065 1 757
split FR940810-0-00065 1 759
longitudinally FR940810-0-00065 1 760
dissolve FR940810-0-00065 1 763
whereas FR940810-0-00065 1 767
remain FR940810-0-00065 1 769
lungs FR940810-0-00065 3 772 843 908
years FR940810-0-00065 3 774 786 804
without FR940810-0-00065 1 775
significant FR940810-0-00065 1 776
dissolution FR940810-0-00065 1 777
measurements FR940810-0-00065 1 780
tissue FR940810-0-00065 1 782
burdens FR940810-0-00065 1 784
many FR940810-0-00065 2 785 803
after FR940810-0-00065 1 787
first FR940810-0-00065 1 788
bear FR940810-0-00065 1 791
no FR940810-0-00065 1 792
relationship FR940810-0-00065 1 793
events FR940810-0-00065 1 797
likely FR940810-0-00065 2 799 995
have FR940810-0-00065 1 800
taken FR940810-0-00065 1 801
place FR940810-0-00065 1 802
before FR940810-0-00065 1 805
clinical FR940810-0-00065 1 806
manifestation FR940810-0-00065 1 807
1273 FR940810-0-00065 1 815
pointed FR940810-0-00065 1 818
postg FR940810-0-00065 1 822
brief FR940810-0-00065 1 823
testified FR940810-0-00065 1 829
while FR940810-0-00065 1 831
observation FR940810-0-00065 1 833
does FR940810-0-00065 1 836
last FR940810-0-00065 1 838
long FR940810-0-00065 1 840
other FR940810-0-00065 1 845
forms FR940810-0-00065 1 846
knowledge FR940810-0-00065 1 852
tr FR940810-0-00065 2 854 912
1074 FR940810-0-00065 2 856 914
there FR940810-0-00065 1 859
recent FR940810-0-00065 1 861
most FR940810-0-00065 1 868
effective FR940810-0-00065 1 869
three FR940810-0-00065 1 872
major FR940810-0-00065 1 873
migrating FR940810-0-00065 1 877
pleura FR940810-0-00065 1 880
present FR940810-0-00065 3 885 902 905
substantial FR940810-0-00065 1 887
amounts FR940810-0-00065 1 888
pleural FR940810-0-00065 2 890 962
plaques FR940810-0-00065 1 891
mesotheliomas FR940810-0-00065 1 893
circumstances FR940810-0-00065 1 897
minimally FR940810-0-00065 1 904
themselves FR940810-0-00065 1 909
agency FR940810-0-00065 1 918
also FR940810-0-00065 1 919
hei FR940810-0-00065 1 923
summing FR940810-0-00065 1 927
up FR940810-0-00065 1 928
discussion FR940810-0-00065 1 930
literature FR940810-0-00065 1 933
search FR940810-0-00065 1 934
examining FR940810-0-00065 1 937
relative FR940810-0-00065 1 942
potency FR940810-0-00065 1 943
inducing FR940810-0-00065 1 947
stated FR940810-0-00065 1 950
: FR940810-0-00065 1 951
rarely FR940810-0-00065 1 960
causes FR940810-0-00065 1 961
conclusive FR940810-0-00065 1 966
absence FR940810-0-00065 1 973
one FR940810-0-00065 1 977
cohorts FR940810-0-00065 1 982
heavily FR940810-0-00065 1 984
worked FR940810-0-00065 1 989
only FR940810-0-00065 1 990
seems FR940810-0-00065 1 994
due FR940810-0-00065 1 998
least FR940810-0-00065 1 1000
part FR940810-0-00065 1 1002
chance FR940810-0-00065 1 1004
1344 FR940810-0-00065 1 1009
623 FR940810-0-00065 1 1011
hei FR940810-0-00066 1 0
concluded FR940810-0-00066 1 1
that FR940810-0-00066 10 2 25 168 175 230 270 288 313 390 456
`` FR940810-0-00066 3 3 413 469
the FR940810-0-00066 26 4 18 23 43 62 69 74 93 98 112 126 190 203 227 255 268 276 300 314 321 331 355 391 442 445 448
mesothelioma FR940810-0-00066 4 5 101 158 182
risk FR940810-0-00066 8 6 183 237 291 316 357 368 424
for FR940810-0-00066 1 7
chrysotile FR940810-0-00066 7 8 108 154 176 213 231 271
was FR940810-0-00066 2 9 365
an FR940810-0-00066 2 10 411
issue FR940810-0-00066 1 11
of FR940810-0-00066 24 12 17 48 61 97 100 212 224 226 238 246 257 267 281 330 333 369 376 393 405 425 438 441 468
disagreement FR940810-0-00066 1 13
; FR940810-0-00066 2 14 87
some FR940810-0-00066 3 15 151 161
members FR940810-0-00066 1 16
literature FR940810-0-00066 1 19
review FR940810-0-00066 1 20
panel FR940810-0-00066 1 21
held FR940810-0-00066 1 22
view FR940810-0-00066 1 24
a FR940810-0-00066 7 26 156 180 234 366 403 422
lower FR940810-0-00066 3 27 157 476
estimate FR940810-0-00066 2 28 96
should FR940810-0-00066 3 29 273 458
be FR940810-0-00066 4 30 36 51 274
recommended FR940810-0-00066 1 31
, FR940810-0-00066 20 32 46 54 123 147 165 189 197 200 222 263 308 325 336 349 383 408 444 452 482
as FR940810-0-00066 5 33 68 243 278 351
it FR940810-0-00066 3 34 298 327
would FR940810-0-00066 1 35
more FR940810-0-00066 1 37
consistent FR940810-0-00066 1 38
with FR940810-0-00066 2 39 421
available FR940810-0-00066 1 40
data FR940810-0-00066 1 41
. FR940810-0-00066 13 42 140 145 187 220 248 283 354 379 432 450 484 489
crucial FR940810-0-00066 1 44
issues FR940810-0-00066 1 45
neither FR940810-0-00066 1 47
which FR940810-0-00066 3 49 341 473
can FR940810-0-00066 1 50
resolved FR940810-0-00066 1 52
unequivocally FR940810-0-00066 1 53
are FR940810-0-00066 3 55 419 435
( FR940810-0-00066 6 56 89 117 134 138 479
1 FR940810-0-00066 1 57
) FR940810-0-00066 6 58 91 122 136 144 488
what FR940810-0-00066 1 59
proportion FR940810-0-00066 1 60
mesotheliomas FR940810-0-00066 1 63
observed FR940810-0-00066 1 64
in FR940810-0-00066 5 65 284 343 359 396
groups FR940810-0-00066 2 66 386
such FR940810-0-00066 1 67
uk FR940810-0-00066 1 70
textile FR940810-0-00066 2 71 129
workers FR940810-0-00066 4 72 77 130 344
and FR940810-0-00066 7 73 88 115 241 337 371 429
us FR940810-0-00066 1 75
insulation FR940810-0-00066 1 76
were FR940810-0-00066 3 78 311 454
caused FR940810-0-00066 2 79 106
by FR940810-0-00066 4 80 107 111 125
their FR940810-0-00066 2 81 388
exposure FR940810-0-00066 7 82 196 262 272 378 407 477
to FR940810-0-00066 12 83 102 155 173 184 194 209 215 260 286 462 464
crocidolite FR940810-0-00066 1 84
or FR940810-0-00066 4 85 120 124 214
amosite FR940810-0-00066 1 86
2 FR940810-0-00066 1 90
whether FR940810-0-00066 2 92 363
best FR940810-0-00066 1 94
general FR940810-0-00066 1 95
ratio FR940810-0-00066 1 99
excess FR940810-0-00066 1 103
lung FR940810-0-00066 5 104 198 239 426 449
cancer FR940810-0-00066 4 105 199 240 370
is FR940810-0-00066 5 109 150 170 265 400
provided FR940810-0-00066 1 110
quebec FR940810-0-00066 2 113 132
miners FR940810-0-00066 1 114
millers FR940810-0-00066 1 116
about FR940810-0-00066 1 118
1:4 FR940810-0-00066 1 119
1:5 FR940810-0-00066 1 121
south FR940810-0-00066 1 127
carolina FR940810-0-00066 1 128
handling FR940810-0-00066 1 131
fiber FR940810-0-00066 4 133 163 218 305
zero FR940810-0-00066 1 135
'' FR940810-0-00066 3 137 416 472
ex FR940810-0-00066 2 139 483
1344 FR940810-0-00066 1 141
p. FR940810-0-00066 1 142
632 FR940810-0-00066 1 143
thus FR940810-0-00066 1 146
although FR940810-0-00066 1 148
there FR940810-0-00066 3 149 169 364
evidence FR940810-0-00066 4 152 172 228 329
linking FR940810-0-00066 1 153
rate FR940810-0-00066 1 159
than FR940810-0-00066 1 160
amphibole FR940810-0-00066 2 162 216
types FR940810-0-00066 3 164 219 306
osha FR940810-0-00066 4 166 264 289 457
believes FR940810-0-00066 1 167
insufficient FR940810-0-00066 1 171
show FR940810-0-00066 1 174
does FR940810-0-00066 1 177
not FR940810-0-00066 2 178 401
present FR940810-0-00066 1 179
significant FR940810-0-00066 3 181 236 367
exposed FR940810-0-00066 4 185 208 345 398
employees FR940810-0-00066 3 186 207 399
furthermore FR940810-0-00066 1 188
major FR940810-0-00066 1 191
disease FR940810-0-00066 2 192 340
linked FR940810-0-00066 1 193
asbestos FR940810-0-00066 12 195 217 232 247 261 282 295 304 324 339 397 406
occurs FR940810-0-00066 1 201
at FR940810-0-00066 5 202 346 373 475 486
same FR940810-0-00066 2 204 277
frequency FR940810-0-00066 1 205
among FR940810-0-00066 1 206
equivalent FR940810-0-00066 1 210
doses FR940810-0-00066 1 211
indeed FR940810-0-00066 1 221
evaluation FR940810-0-00066 1 223
all FR940810-0-00066 2 225 303
indicates FR940810-0-00066 1 229
presents FR940810-0-00066 1 233
similar FR940810-0-00066 1 235
asbestosis FR940810-0-00066 2 242 372
other FR940810-0-00066 4 244 279 309 338
forms FR940810-0-00066 2 245 280
since FR940810-0-00066 1 249
these FR940810-0-00066 2 250 465
adverse FR940810-0-00066 1 251
health FR940810-0-00066 1 252
effects FR940810-0-00066 1 253
constitute FR940810-0-00066 1 254
majority FR940810-0-00066 1 256
diseases FR940810-0-00066 1 258
related FR940810-0-00066 1 259
still FR940810-0-00066 1 266
opinion FR940810-0-00066 1 269
treated FR940810-0-00066 2 275 299
addition FR940810-0-00066 1 285
contentions FR940810-0-00066 2 287 310
's FR940810-0-00066 1 290
assessment FR940810-0-00066 3 292 317 358
had FR940810-0-00066 1 293
overstated FR940810-0-00066 1 294
risks FR940810-0-00066 4 296 301 322 467
because FR940810-0-00066 3 297 326 417
from FR940810-0-00066 2 302 323
equally FR940810-0-00066 1 307
made FR940810-0-00066 2 312 455
earlier FR940810-0-00066 2 315 356
may FR940810-0-00066 1 318
have FR940810-0-00066 1 319
understated FR940810-0-00066 1 320
ignored FR940810-0-00066 1 328
incidence FR940810-0-00066 1 332
pleural FR940810-0-00066 3 334 394 433
plaques FR940810-0-00066 3 335 395 434
occurred FR940810-0-00066 2 342 474
low FR940810-0-00066 1 347
levels FR940810-0-00066 3 348 375 478
primarily FR940810-0-00066 1 350
building FR940810-0-00066 1 352
custodians FR940810-0-00066 1 353
1984 FR940810-0-00066 1 360
focused FR940810-0-00066 1 361
on FR940810-0-00066 1 362
various FR940810-0-00066 2 374 384
cumulative FR940810-0-00066 1 377
during FR940810-0-00066 1 380
this FR940810-0-00066 1 381
hearing FR940810-0-00066 1 382
labor FR940810-0-00066 1 385
stated FR940810-0-00066 1 387
position FR940810-0-00066 1 389
presence FR940810-0-00066 1 392
only FR940810-0-00066 1 402
marker FR940810-0-00066 1 404
but FR940810-0-00066 1 409
also FR940810-0-00066 1 410
independent FR940810-0-00066 1 412
material FR940810-0-00066 2 414 470
impairment FR940810-0-00066 3 415 428 471
they FR940810-0-00066 1 418
associated FR940810-0-00066 1 420
greater FR940810-0-00066 1 423
function FR940810-0-00066 1 427
pleuritic FR940810-0-00066 1 430
pain FR940810-0-00066 1 431
focal FR940810-0-00066 1 436
areas FR940810-0-00066 1 437
fibrous FR940810-0-00066 1 439
thickening FR940810-0-00066 1 440
pleura FR940810-0-00066 1 443
membrane FR940810-0-00066 1 446
lining FR940810-0-00066 1 447
further FR940810-0-00066 1 451
suggestions FR940810-0-00066 1 453
reduce FR940810-0-00066 1 459
its FR940810-0-00066 1 460
pels FR940810-0-00066 1 461
correspond FR940810-0-00066 1 463
increased FR940810-0-00066 1 466
see FR940810-0-00066 1 480
eg FR940810-0-00066 1 481
143 FR940810-0-00066 1 485
3537 FR940810-0-00066 1 487
evidence FR940810-0-00067 2 0 436
submitted FR940810-0-00067 2 1 637
during FR940810-0-00067 2 2 764
the FR940810-0-00067 23 3 12 80 139 173 185 209 248 277 389 432 461 485 492 574 606 621 677 718 740 757 765 775
rulemaking FR940810-0-00067 1 4
consisted FR940810-0-00067 2 5 145
of FR940810-0-00067 30 6 14 112 126 146 172 184 208 214 234 254 274 287 294 337 370 398 413 429 437 494 506 600 624 640 720 761 769 802 805
testimony FR940810-0-00067 1 7
and FR940810-0-00067 21 8 21 42 57 99 104 162 211 330 345 423 458 541 651 693 722 736 744 772 777 788
studies FR940810-0-00067 9 9 41 140 241 519 642 666 742 779
which FR940810-0-00067 8 10 159 313 325 331 497 520 643
in FR940810-0-00067 17 11 60 75 131 136 166 180 205 247 312 324 376 407 489 586 664 700
view FR940810-0-00067 1 13
some FR940810-0-00067 1 15
participants FR940810-0-00067 1 16
showed FR940810-0-00067 1 17
lung FR940810-0-00067 9 18 55 76 97 113 278 338 704 725
function FR940810-0-00067 4 19 77 114 705
decrement FR940810-0-00067 2 20 74
resulting FR940810-0-00067 1 22
excess FR940810-0-00067 1 23
disease FR940810-0-00067 1 24
among FR940810-0-00067 1 25
workers FR940810-0-00067 5 26 275 297 314 399
exposed FR940810-0-00067 5 27 128 385 583 613
at FR940810-0-00067 4 28 79 425 618
low FR940810-0-00067 4 29 510 522 681
levels FR940810-0-00067 1 30
. FR940810-0-00067 35 31 117 120 138 156 175 204 239 267 270 343 347 358 363 367 388 447 453 488 528 539 543 548 588 605 629 635 648 656 659 706 732 734 793 807
for FR940810-0-00067 15 32 51 89 96 100 271 317 456 468 484 589 620 698 759 784
example FR940810-0-00067 1 33
bctd FR940810-0-00067 2 34 798
witness FR940810-0-00067 1 35
dr. FR940810-0-00067 9 36 121 143 244 308 515 534 669 747
christine FR940810-0-00067 1 37
oliver FR940810-0-00067 6 38 122 144 245 516 670
described FR940810-0-00067 2 39 242
various FR940810-0-00067 1 40
concluded FR940810-0-00067 5 43 333 391 608 709
: FR940810-0-00067 4 44 251 291 350
pleural FR940810-0-00067 7 45 64 84 164 326 442 495
plaques FR940810-0-00067 7 46 65 85 165 327 496 721
*** FR940810-0-00067 3 47 63 78
were FR940810-0-00067 9 48 315 328 332 378 674 714 750 799
a FR940810-0-00067 11 49 87 225 252 292 351 531 556 638 680 688
predictor FR940810-0-00067 1 50
increased FR940810-0-00067 1 52
mortality FR940810-0-00067 2 53 340
from FR940810-0-00067 4 54 555 564 729
cancer FR940810-0-00067 4 56 98 339 558
malignant FR940810-0-00067 2 58 101
mesothelioma FR940810-0-00067 5 59 102 527 553 625
subsequent FR940810-0-00067 2 61 622
years FR940810-0-00067 4 62 321 428 472
have FR940810-0-00067 6 66 106 301 383 402 581
also FR940810-0-00067 3 67 107 738
been FR940810-0-00067 4 68 108 384 582
shown FR940810-0-00067 1 69
to FR940810-0-00067 24 70 93 129 197 220 300 319 334 382 386 401 405 415 418 491 509 566 580 584 614 703 717 756 781
be FR940810-0-00067 2 71 335
associated FR940810-0-00067 4 72 109 231 284
with FR940810-0-00067 10 73 110 216 232 285 424 431 470 477 526
very FR940810-0-00067 1 81
least FR940810-0-00067 2 82 426
, FR940810-0-00067 33 83 91 103 187 222 229 246 260 276 311 323 353 361 365 392 410 422 449 460 514 530 546 560 573 595 631 667 676 684 692 743 771 786
are FR940810-0-00067 3 86 498 617
marker FR940810-0-00067 1 88
exposure FR940810-0-00067 8 90 196 219 305 404 414 525 602
sufficient FR940810-0-00067 1 92
increase FR940810-0-00067 1 94
risk FR940810-0-00067 3 95 463 619
they FR940810-0-00067 4 105 644 660 685
loss FR940810-0-00067 1 111
( FR940810-0-00067 13 115 154 169 183 265 298 341 356 445 537 591 627 654
tr FR940810-0-00067 5 116 155 342 362 538
10356 FR940810-0-00067 1 118
) FR940810-0-00067 12 119 158 171 191 269 306 349 369 452 594 634 658
recommended FR940810-0-00067 1 123
medical FR940810-0-00067 1 124
surveillance FR940810-0-00067 1 125
those FR940810-0-00067 4 127 215 469 478
asbestos FR940810-0-00067 11 130 198 221 304 387 416 512 524 585 601 791
their FR940810-0-00067 1 132
capacity FR940810-0-00067 1 133
as FR940810-0-00067 7 134 201 236 289 380 500 578
custodians FR940810-0-00067 3 135 153 259
buildings FR940810-0-00067 2 137 587
considered FR940810-0-00067 1 141
by FR940810-0-00067 7 142 243 307 354 533 646 797
one FR940810-0-00067 1 147
involving FR940810-0-00067 1 148
120 FR940810-0-00067 1 149
boston FR940810-0-00067 1 150
public FR940810-0-00067 1 151
school FR940810-0-00067 8 152 202 237 258 373 408 419 486
1026 FR940810-0-00067 1 157
she FR940810-0-00067 3 160 177 223
conducted FR940810-0-00067 1 161
found FR940810-0-00067 2 163 329
33 FR940810-0-00067 1 167
% FR940810-0-00067 5 168 182 207 213 593
n=40 FR940810-0-00067 1 170
group FR940810-0-00067 2 174 210
further FR940810-0-00067 1 176
noted FR940810-0-00067 1 178
that FR940810-0-00067 7 179 609 668 710 723 746 773
21 FR940810-0-00067 1 181
40 FR940810-0-00067 1 186
or FR940810-0-00067 2 188 473
12 FR940810-0-00067 1 189
individuals FR940810-0-00067 2 190 611
there FR940810-0-00067 1 192
was FR940810-0-00067 4 193 283 464 603
no FR940810-0-00067 3 194 217 596
known FR940810-0-00067 2 195 400
outside FR940810-0-00067 2 199 218
work FR940810-0-00067 2 200 288
custodian FR940810-0-00067 3 203 238 290
18 FR940810-0-00067 1 206
17 FR940810-0-00067 1 212
observed FR940810-0-00067 1 224
restrictive FR940810-0-00067 1 226
pulmonary FR940810-0-00067 1 227
defect FR940810-0-00067 1 228
significantly FR940810-0-00067 1 230
duration FR940810-0-00067 2 233 286
employment FR940810-0-00067 4 235 421 430 475
other FR940810-0-00067 7 240 518 597 730 741 789 794
docket FR940810-0-00067 1 249
include FR940810-0-00067 1 250
study FR940810-0-00067 6 253 293 352 532 672 678
666 FR940810-0-00067 1 255
new FR940810-0-00067 1 256
york FR940810-0-00067 1 257
reporting FR940810-0-00067 1 261
only FR940810-0-00067 1 262
xray FR940810-0-00067 2 263 282
data FR940810-0-00067 1 264
ex FR940810-0-00067 9 266 346 357 366 446 542 547 628 655
47 FR940810-0-00067 1 268
all FR940810-0-00067 1 272
groups FR940810-0-00067 1 273
abnormality FR940810-0-00067 1 279
seen FR940810-0-00067 1 280
on FR940810-0-00067 2 281 552
1117 FR940810-0-00067 1 295
insulation FR940810-0-00067 1 296
likely FR940810-0-00067 4 299 381 579 598
had FR940810-0-00067 5 302 434 480 679 686
extensive FR940810-0-00067 1 303
irving FR940810-0-00067 1 309
selikoff FR940810-0-00067 2 310 748
followed FR940810-0-00067 1 316
up FR940810-0-00067 1 318
27 FR940810-0-00067 2 320 766
prospectively FR940810-0-00067 1 322
predictive FR940810-0-00067 1 336
1036 FR940810-0-00067 2 344 364
124a FR940810-0-00067 1 348
balmes FR940810-0-00067 2 355 778
124 FR940810-0-00067 2 359 544
dd FR940810-0-00067 1 360
1374 FR940810-0-00067 4 368 448 549 630
approximately FR940810-0-00067 1 371
900 FR940810-0-00067 1 372
district FR940810-0-00067 4 374 420 433 487
employees FR940810-0-00067 1 375
california FR940810-0-00067 1 377
determined FR940810-0-00067 1 379
authors FR940810-0-00067 1 390
`` FR940810-0-00067 3 393 610 751
more FR940810-0-00067 2 394 474
than FR940810-0-00067 1 395
11 FR940810-0-00067 1 396
percent FR940810-0-00067 1 397
sustained FR940810-0-00067 1 403
acm FR940810-0-00067 1 406
building FR940810-0-00067 1 409
without FR940810-0-00067 1 411
history FR940810-0-00067 1 412
prior FR940810-0-00067 1 417
10 FR940810-0-00067 3 427 471 590
radiographic FR940810-0-00067 1 435
parenchymal FR940810-0-00067 1 438
asbestosis FR940810-0-00067 1 439
and/or FR940810-0-00067 1 440
asbestosrelated FR940810-0-00067 1 441
thickening FR940810-0-00067 1 443
'' FR940810-0-00067 3 444 626 754
p. FR940810-0-00067 2 450 632
547 FR940810-0-00067 1 451
after FR940810-0-00067 1 454
adjusting FR940810-0-00067 1 455
smoking FR940810-0-00067 2 457 787
age FR940810-0-00067 3 459 699 785
relative FR940810-0-00067 1 462
1.3 FR940810-0-00067 1 465
times FR940810-0-00067 1 466
greater FR940810-0-00067 1 467
compared FR940810-0-00067 1 476
who FR940810-0-00067 1 479
just FR940810-0-00067 1 481
begun FR940810-0-00067 1 482
working FR940810-0-00067 1 483
addition FR940810-0-00067 1 490
occurrence FR940810-0-00067 1 493
viewed FR940810-0-00067 1 499
presenting FR940810-0-00067 1 501
an FR940810-0-00067 1 502
independent FR940810-0-00067 1 503
material FR940810-0-00067 1 504
impairment FR940810-0-00067 1 505
health FR940810-0-00067 1 507
due FR940810-0-00067 2 508 755
level FR940810-0-00067 2 511 523
exposures FR940810-0-00067 2 513 792
cited FR940810-0-00067 2 517 796
correlated FR940810-0-00067 1 521
thus FR940810-0-00067 1 529
h. FR940810-0-00067 2 535 649
anderson FR940810-0-00067 2 536 776
1032 FR940810-0-00067 1 540
ee FR940810-0-00067 1 545
using FR940810-0-00067 2 550 568
information FR940810-0-00067 2 551 572
cases FR940810-0-00067 1 554
wisconsin FR940810-0-00067 1 557
registry FR940810-0-00067 1 559
analyzed FR940810-0-00067 1 561
359 FR940810-0-00067 1 562
deaths FR940810-0-00067 1 563
1959 FR940810-0-00067 1 565
1989. FR940810-0-00067 1 567
death FR940810-0-00067 1 569
certificate FR940810-0-00067 1 570
occupational FR940810-0-00067 1 571
researchers FR940810-0-00067 1 575
hypothesized FR940810-0-00067 1 576
41 FR940810-0-00067 1 577
34 FR940810-0-00067 1 592
source FR940810-0-00067 1 599
identified FR940810-0-00067 1 604
paper FR940810-0-00067 1 607
occupationally FR940810-0-00067 1 612
ine FR940810-0-00067 1 615
acbm FR940810-0-00067 1 616
development FR940810-0-00067 2 623 760
570 FR940810-0-00067 1 633
sba FR940810-0-00067 1 636
critique FR940810-0-00067 1 639
these FR940810-0-00067 3 641 665 707
commissioned FR940810-0-00067 1 645
drs FR940810-0-00067 2 647 733
weill FR940810-0-00067 2 650 735
j. FR940810-0-00067 1 652
hughes FR940810-0-00067 2 653 737
122 FR940810-0-00067 1 657
suggested FR940810-0-00067 1 661
potential FR940810-0-00067 3 662 758 803
biases FR940810-0-00067 1 663
's FR940810-0-00067 2 671 749
subjects FR940810-0-00067 1 673
volunteers FR940810-0-00067 1 675
participation FR940810-0-00067 1 682
rate FR940810-0-00067 1 683
used FR940810-0-00067 1 687
nond FR940810-0-00067 1 689
classification FR940810-0-00067 1 690
system FR940810-0-00067 1 691
did FR940810-0-00067 1 694
not FR940810-0-00067 2 695 715
adequately FR940810-0-00067 2 696 782
account FR940810-0-00067 1 697
relating FR940810-0-00067 1 701
restriction FR940810-0-00067 1 702
reviewers FR940810-0-00067 1 708
spirometric FR940810-0-00067 1 711
functional FR940810-0-00067 1 712
measurements FR940810-0-00067 1 713
related FR940810-0-00067 1 716
presence FR940810-0-00067 1 719
reduced FR940810-0-00067 1 724
volume FR940810-0-00067 1 726
could FR940810-0-00067 1 727
result FR940810-0-00067 1 728
factors FR940810-0-00067 1 731
examined FR940810-0-00067 1 739
argued FR940810-0-00067 1 745
fatally FR940810-0-00067 1 752
flawed FR940810-0-00067 1 753
unmeasured FR940810-0-00067 1 762
changes FR940810-0-00067 1 763
year FR940810-0-00067 1 767
period FR940810-0-00067 1 768
followup FR940810-0-00067 1 770
both FR940810-0-00067 1 774
failed FR940810-0-00067 1 780
adjust FR940810-0-00067 1 783
direct FR940810-0-00067 1 790
reports FR940810-0-00067 1 795
dismissed FR940810-0-00067 1 800
because FR940810-0-00067 1 801
sources FR940810-0-00067 1 804
bias FR940810-0-00067 1 806
dr. FR940810-0-00068 5 0 82 95 120 209
oliver FR940810-0-00068 1 1
rebutted FR940810-0-00068 1 2
these FR940810-0-00068 1 3
arguments FR940810-0-00068 1 4
( FR940810-0-00068 3 5 97 217
ex FR940810-0-00068 3 6 98 218
143 FR940810-0-00068 3 7 100 220
, FR940810-0-00068 8 8 20 55 69 101 119 122 221
attachment FR940810-0-00068 3 9 102 222
f FR940810-0-00068 1 10
) FR940810-0-00068 3 11 104 224
. FR940810-0-00068 9 12 81 99 105 151 184 208 219 225
she FR940810-0-00068 2 13 16
argued FR940810-0-00068 1 14
that FR940810-0-00068 10 15 27 56 71 109 124 129 155 187 228
had FR940810-0-00068 2 17 112
adequate FR940810-0-00068 1 18
controls FR940810-0-00068 1 19
adequately FR940810-0-00068 1 21
accounted FR940810-0-00068 1 22
for FR940810-0-00068 2 23 77
age FR940810-0-00068 1 24
and FR940810-0-00068 7 25 36 46 70 123 165 173
demonstrated FR940810-0-00068 1 26
pleural FR940810-0-00068 3 28 72 206
plaques FR940810-0-00068 3 29 73 207
were FR940810-0-00068 3 30 163 166
significantly FR940810-0-00068 3 31 60 237
associated FR940810-0-00068 2 32 61
with FR940810-0-00068 4 33 50 62 94
both FR940810-0-00068 1 34
latency FR940810-0-00068 1 35
duration FR940810-0-00068 2 37 63
of FR940810-0-00068 5 38 64 91 136 203
work FR940810-0-00068 2 39 65
as FR940810-0-00068 2 40 66
custodian FR940810-0-00068 2 41 68
in FR940810-0-00068 5 42 47 141 148 156
the FR940810-0-00068 8 43 48 87 137 142 146 214 229
total FR940810-0-00068 1 44
group FR940810-0-00068 3 45 49 172
no FR940810-0-00068 2 51 127
known FR940810-0-00068 1 52
other FR940810-0-00068 1 53
exposure FR940810-0-00068 2 54 133
lung FR940810-0-00068 3 57 78 143
restriction FR940810-0-00068 1 58
was FR940810-0-00068 1 59
a FR940810-0-00068 3 67 116 168
mark FR940810-0-00068 1 74
increased FR940810-0-00068 1 75
risk FR940810-0-00068 1 76
cancer FR940810-0-00068 1 79
mortality FR940810-0-00068 1 80
levin FR940810-0-00068 1 83
also FR940810-0-00068 2 84 211
responded FR940810-0-00068 2 85 212
to FR940810-0-00068 5 86 179 196 213 232
reviewer FR940810-0-00068 1 88
's FR940810-0-00068 1 89
criticism FR940810-0-00068 1 90
his FR940810-0-00068 2 92 157
studies FR940810-0-00068 1 93
selikoff FR940810-0-00068 2 96 121
g FR940810-0-00068 1 103
he FR940810-0-00068 4 106 152 185 226
pointed FR940810-0-00068 1 107
out FR940810-0-00068 1 108
all FR940810-0-00068 1 110
xrays FR940810-0-00068 2 111 147
been FR940810-0-00068 1 113
read FR940810-0-00068 1 114
by FR940810-0-00068 1 115
single FR940810-0-00068 1 117
reader FR940810-0-00068 1 118
there FR940810-0-00068 1 125
is FR940810-0-00068 1 126
evidence FR940810-0-00068 1 128
smoking FR940810-0-00068 1 130
without FR940810-0-00068 1 131
asbestos FR940810-0-00068 1 132
increases FR940810-0-00068 1 134
appearance FR940810-0-00068 1 135
small FR940810-0-00068 1 138
irregular FR940810-0-00068 1 139
opacities FR940810-0-00068 1 140
seen FR940810-0-00068 1 144
on FR940810-0-00068 1 145
their FR940810-0-00068 1 149
study FR940810-0-00068 2 150 158
further FR940810-0-00068 1 153
noted FR940810-0-00068 1 154
only FR940810-0-00068 1 159
actively FR940810-0-00068 1 160
working FR940810-0-00068 1 161
custodians FR940810-0-00068 1 162
included FR940810-0-00068 1 164
therefore FR940810-0-00068 2 167 175
`` FR940810-0-00068 1 169
survivor FR940810-0-00068 1 170
'' FR940810-0-00068 1 171
would FR940810-0-00068 3 174 192 236
not FR940810-0-00068 2 176 193
be FR940810-0-00068 2 177 194
expected FR940810-0-00068 2 178 195
report FR940810-0-00068 1 180
pulmonary FR940810-0-00068 1 181
dysfunction FR940810-0-00068 1 182
frequently FR940810-0-00068 1 183
claimed FR940810-0-00068 1 186
relatively FR940810-0-00068 1 188
unexposed FR940810-0-00068 1 189
subject FR940810-0-00068 1 190
groups FR940810-0-00068 1 191
have FR940810-0-00068 1 197
more FR940810-0-00068 1 198
than FR940810-0-00068 1 199
an FR940810-0-00068 1 200
upper FR940810-0-00068 1 201
limit FR940810-0-00068 1 202
3 FR940810-0-00068 1 204
% FR940810-0-00068 1 205
anderson FR940810-0-00068 1 210
weill/hughes FR940810-0-00068 1 215
comments FR940810-0-00068 1 216
h FR940810-0-00068 1 223
asserted FR940810-0-00068 1 227
review FR940810-0-00068 1 230
fails FR940810-0-00068 1 231
explain FR940810-0-00068 1 233
how FR940810-0-00068 1 234
biases FR940810-0-00068 1 235
increase FR940810-0-00068 1 238
